Tests an inhaled nitric oxide system for newborn lung pressure
Part of Lungs & breathing clinical trials.
This study looks at whether an inhaled nitric oxide generator and delivery system can help newborns with high lung blood pressure (pulmonary hypertension). It may help improve oxygen levels during breathing support, but it requires specific medical eligibility and informed consent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- A clinician must decide you would benefit from inhaled nitric oxide and choose this device for your newborn
- Your newborn must be admitted to the hospital’s Neonatology unit
- Your newborn must have pulmonary hypertension and need breathing support now or soon
- Your oxygenation index (OI) must be at least 8 before starting treatment
- A parent or legal representative must sign informed consent after understanding the benefits and risks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether inhaled nitric oxide gas can help full-term newborns who have severe breathing problems and high blood pressure in their lungs. It aims to improve oxygen levels and reduce the need for more intensive support.
This trial tests whether breathing in nitric oxide gas can improve oxygen levels in adults with moderate to severe acute respiratory distress syndrome (a serious lung condition often caused by pneumonia or sepsis). If you have this condition and meet the requirements, you may be able to join.
This trial tests a new, smart way to slowly reduce (wean) the inhaled nitric oxide gas that helps babies with a serious lung condition called PPHN. If your baby is already responding well to iNO and needs it for at least 24 hours, this study might help make the weaning process safer and more effective.
This trial tests whether inhaled nitric oxide gas helps newborns with a specific type of congenital diaphragmatic hernia (a hole in the diaphragm that lets organs move into the chest) who have low oxygen and high blood pressure in their lungs.
This trial studies whether stopping inhaled nitric oxide (a breathing medicine) can be safely used in newborns with congenital diaphragmatic hernia (CDH). It may help the team decide the best way to use this medicine during early newborn care.
This trial tests whether giving nitric oxide gas through a breathing tube can improve oxygen levels in patients with severe obesity who are on a ventilator. It may help those whose lungs are struggling due to acute respiratory failure.
Hear when a new Pulmonary Hypertension of Newborn trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.